img

Global Recombinant Human Follicle-stimulating Hormone Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Recombinant Human Follicle-stimulating Hormone Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Recombinant Human Follicle-stimulating Hormone Market
The global Recombinant Human Follicle-stimulating Hormone market is projected to grow from US$ million in 2024 to US$ million by 2034, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Recombinant Human Follicle-stimulating Hormone is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Recombinant Human Follicle-stimulating Hormone is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Recombinant Human Follicle-stimulating Hormone is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The global key companies of Recombinant Human Follicle-stimulating Hormone include Merck, Ferring, Livzon, Gedeon Richter, GenSci, Teva, ChangChun High & New Technology, ABL and Scripps Laboratories, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Recombinant Human Follicle-stimulating Hormone market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2024, and projections of CAGR through 2034.
This report researches the key producers of Recombinant Human Follicle-stimulating Hormone, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Recombinant Human Follicle-stimulating Hormone, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Recombinant Human Follicle-stimulating Hormone revenue, market share and industry ranking of main companies, data from 2018 to 2024. Identification of the major stakeholders in the global Recombinant Human Follicle-stimulating Hormone market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2034. Evaluation and forecast the market size for Recombinant Human Follicle-stimulating Hormone revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Merck, Ferring, Livzon, Gedeon Richter, GenSci, Teva, ChangChun High & New Technology, ABL and Scripps Laboratories, etc.



By Company


Merck
Ferring
Livzon
Gedeon Richter
GenSci
Teva
ChangChun High & New Technology
ABL
Scripps Laboratories
Alphamab Oncology
Hunan Jingfeng Pharmaceutical
Qilu Pharmaceutical
Beijing SL Pharmaceutical
Segment by Type
75IU
150IU
Others

Segment by Application


Infertility Treatment
Assisted Reproductive Technology
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Revenue of Recombinant Human Follicle-stimulating Hormone in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3Detailed analysis of Recombinant Human Follicle-stimulating Hormone companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8China by type and by application revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Human Follicle-stimulating Hormone revenue, gross margin, and recent development, etc.
Chapter 12Analyst's Viewpoints/Conclusions

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant Human Follicle-stimulating Hormone Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 75IU
1.2.3 150IU
1.2.4 Others
1.3 Market by Application
1.3.1 Global Recombinant Human Follicle-stimulating Hormone Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Infertility Treatment
1.3.3 Assisted Reproductive Technology
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Recombinant Human Follicle-stimulating Hormone Market Perspective (2018-2034)
2.2 Global Recombinant Human Follicle-stimulating Hormone Growth Trends by Region
2.2.1 Recombinant Human Follicle-stimulating Hormone Market Size by Region: 2018 VS 2022 VS 2034
2.2.2 Recombinant Human Follicle-stimulating Hormone Historic Market Size by Region (2018-2024)
2.2.3 Recombinant Human Follicle-stimulating Hormone Forecasted Market Size by Region (2024-2034)
2.3 Recombinant Human Follicle-stimulating Hormone Market Dynamics
2.3.1 Recombinant Human Follicle-stimulating Hormone Industry Trends
2.3.2 Recombinant Human Follicle-stimulating Hormone Market Drivers
2.3.3 Recombinant Human Follicle-stimulating Hormone Market Challenges
2.3.4 Recombinant Human Follicle-stimulating Hormone Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Recombinant Human Follicle-stimulating Hormone by Players
3.1.1 Global Recombinant Human Follicle-stimulating Hormone Revenue by Players (2018-2024)
3.1.2 Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Players (2018-2024)
3.2 Global Recombinant Human Follicle-stimulating Hormone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Recombinant Human Follicle-stimulating Hormone, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Recombinant Human Follicle-stimulating Hormone Market Concentration Ratio
3.4.1 Global Recombinant Human Follicle-stimulating Hormone Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Human Follicle-stimulating Hormone Revenue in 2022
3.5 Global Key Players of Recombinant Human Follicle-stimulating Hormone Head office and Area Served
3.6 Global Key Players of Recombinant Human Follicle-stimulating Hormone, Product and Application
3.7 Global Key Players of Recombinant Human Follicle-stimulating Hormone, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant Human Follicle-stimulating Hormone Breakdown Data by Type
4.1 Global Recombinant Human Follicle-stimulating Hormone Historic Market Size by Type (2018-2024)
4.2 Global Recombinant Human Follicle-stimulating Hormone Forecasted Market Size by Type (2024-2034)
5 Recombinant Human Follicle-stimulating Hormone Breakdown Data by Application
5.1 Global Recombinant Human Follicle-stimulating Hormone Historic Market Size by Application (2018-2024)
5.2 Global Recombinant Human Follicle-stimulating Hormone Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Recombinant Human Follicle-stimulating Hormone Market Size (2018-2034)
6.2 North America Recombinant Human Follicle-stimulating Hormone Market Size by Type
6.2.1 North America Recombinant Human Follicle-stimulating Hormone Market Size by Type (2018-2024)
6.2.2 North America Recombinant Human Follicle-stimulating Hormone Market Size by Type (2024-2034)
6.2.3 North America Recombinant Human Follicle-stimulating Hormone Market Share by Type (2018-2034)
6.3 North America Recombinant Human Follicle-stimulating Hormone Market Size by Application
6.3.1 North America Recombinant Human Follicle-stimulating Hormone Market Size by Application (2018-2024)
6.3.2 North America Recombinant Human Follicle-stimulating Hormone Market Size by Application (2024-2034)
6.3.3 North America Recombinant Human Follicle-stimulating Hormone Market Share by Application (2018-2034)
6.4 North America Recombinant Human Follicle-stimulating Hormone Market Size by Country
6.4.1 North America Recombinant Human Follicle-stimulating Hormone Market Size by Country: 2018 VS 2022 VS 2034
6.4.2 North America Recombinant Human Follicle-stimulating Hormone Market Size by Country (2018-2024)
6.4.3 North America Recombinant Human Follicle-stimulating Hormone Market Size by Country (2024-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Recombinant Human Follicle-stimulating Hormone Market Size (2018-2034)
7.2 Europe Recombinant Human Follicle-stimulating Hormone Market Size by Type
7.2.1 Europe Recombinant Human Follicle-stimulating Hormone Market Size by Type (2018-2024)
7.2.2 Europe Recombinant Human Follicle-stimulating Hormone Market Size by Type (2024-2034)
7.2.3 Europe Recombinant Human Follicle-stimulating Hormone Market Share by Type (2018-2034)
7.3 Europe Recombinant Human Follicle-stimulating Hormone Market Size by Application
7.3.1 Europe Recombinant Human Follicle-stimulating Hormone Market Size by Application (2018-2024)
7.3.2 Europe Recombinant Human Follicle-stimulating Hormone Market Size by Application (2024-2034)
7.3.3 Europe Recombinant Human Follicle-stimulating Hormone Market Share by Application (2018-2034)
7.4 Europe Recombinant Human Follicle-stimulating Hormone Market Size by Country
7.4.1 Europe Recombinant Human Follicle-stimulating Hormone Market Size by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Recombinant Human Follicle-stimulating Hormone Market Size by Country (2018-2024)
7.4.3 Europe Recombinant Human Follicle-stimulating Hormone Market Size by Country (2024-2034)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Recombinant Human Follicle-stimulating Hormone Market Size (2018-2034)
8.2 China Recombinant Human Follicle-stimulating Hormone Market Size by Type
8.2.1 China Recombinant Human Follicle-stimulating Hormone Market Size by Type (2018-2024)
8.2.2 China Recombinant Human Follicle-stimulating Hormone Market Size by Type (2024-2034)
8.2.3 China Recombinant Human Follicle-stimulating Hormone Market Share by Type (2018-2034)
8.3 China Recombinant Human Follicle-stimulating Hormone Market Size by Application
8.3.1 China Recombinant Human Follicle-stimulating Hormone Market Size by Application (2018-2024)
8.3.2 China Recombinant Human Follicle-stimulating Hormone Market Size by Application (2024-2034)
8.3.3 China Recombinant Human Follicle-stimulating Hormone Market Share by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Recombinant Human Follicle-stimulating Hormone Market Size (2018-2034)
9.2 Asia Recombinant Human Follicle-stimulating Hormone Market Size by Type
9.2.1 Asia Recombinant Human Follicle-stimulating Hormone Market Size by Type (2018-2024)
9.2.2 Asia Recombinant Human Follicle-stimulating Hormone Market Size by Type (2024-2034)
9.2.3 Asia Recombinant Human Follicle-stimulating Hormone Market Share by Type (2018-2034)
9.3 Asia Recombinant Human Follicle-stimulating Hormone Market Size by Application
9.3.1 Asia Recombinant Human Follicle-stimulating Hormone Market Size by Application (2018-2024)
9.3.2 Asia Recombinant Human Follicle-stimulating Hormone Market Size by Application (2024-2034)
9.3.3 Asia Recombinant Human Follicle-stimulating Hormone Market Share by Application (2018-2034)
9.4 Asia Recombinant Human Follicle-stimulating Hormone Market Size by Region
9.4.1 Asia Recombinant Human Follicle-stimulating Hormone Market Size by Region: 2018 VS 2022 VS 2034
9.4.2 Asia Recombinant Human Follicle-stimulating Hormone Market Size by Region (2018-2024)
9.4.3 Asia Recombinant Human Follicle-stimulating Hormone Market Size by Region (2024-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Recombinant Human Follicle-stimulating Hormone Market Size (2018-2034)
10.2 Middle East, Africa, and Latin America Recombinant Human Follicle-stimulating Hormone Market Size by Type
10.2.1 Middle East, Africa, and Latin America Recombinant Human Follicle-stimulating Hormone Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Recombinant Human Follicle-stimulating Hormone Market Size by Type (2024-2034)
10.2.3 Middle East, Africa, and Latin America Recombinant Human Follicle-stimulating Hormone Market Share by Type (2018-2034)
10.3 Middle East, Africa, and Latin America Recombinant Human Follicle-stimulating Hormone Market Size by Application
10.3.1 Middle East, Africa, and Latin America Recombinant Human Follicle-stimulating Hormone Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Recombinant Human Follicle-stimulating Hormone Market Size by Application (2024-2034)
10.3.3 Middle East, Africa, and Latin America Recombinant Human Follicle-stimulating Hormone Market Share by Application (2018-2034)
10.4 Middle East, Africa, and Latin America Recombinant Human Follicle-stimulating Hormone Market Size by Country
10.4.1 Middle East, Africa, and Latin America Recombinant Human Follicle-stimulating Hormone Market Size by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa, and Latin America Recombinant Human Follicle-stimulating Hormone Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Recombinant Human Follicle-stimulating Hormone Market Size by Country (2024-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Recombinant Human Follicle-stimulating Hormone Introduction
11.1.4 Merck Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2024)
11.1.5 Merck Recent Developments
11.2 Ferring
11.2.1 Ferring Company Details
11.2.2 Ferring Business Overview
11.2.3 Ferring Recombinant Human Follicle-stimulating Hormone Introduction
11.2.4 Ferring Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2024)
11.2.5 Ferring Recent Developments
11.3 Livzon
11.3.1 Livzon Company Details
11.3.2 Livzon Business Overview
11.3.3 Livzon Recombinant Human Follicle-stimulating Hormone Introduction
11.3.4 Livzon Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2024)
11.3.5 Livzon Recent Developments
11.4 Gedeon Richter
11.4.1 Gedeon Richter Company Details
11.4.2 Gedeon Richter Business Overview
11.4.3 Gedeon Richter Recombinant Human Follicle-stimulating Hormone Introduction
11.4.4 Gedeon Richter Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2024)
11.4.5 Gedeon Richter Recent Developments
11.5 GenSci
11.5.1 GenSci Company Details
11.5.2 GenSci Business Overview
11.5.3 GenSci Recombinant Human Follicle-stimulating Hormone Introduction
11.5.4 GenSci Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2024)
11.5.5 GenSci Recent Developments
11.6 Teva
11.6.1 Teva Company Details
11.6.2 Teva Business Overview
11.6.3 Teva Recombinant Human Follicle-stimulating Hormone Introduction
11.6.4 Teva Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2024)
11.6.5 Teva Recent Developments
11.7 ChangChun High & New Technology
11.7.1 ChangChun High & New Technology Company Details
11.7.2 ChangChun High & New Technology Business Overview
11.7.3 ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Introduction
11.7.4 ChangChun High & New Technology Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2024)
11.7.5 ChangChun High & New Technology Recent Developments
11.8 ABL
11.8.1 ABL Company Details
11.8.2 ABL Business Overview
11.8.3 ABL Recombinant Human Follicle-stimulating Hormone Introduction
11.8.4 ABL Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2024)
11.8.5 ABL Recent Developments
11.9 Scripps Laboratories
11.9.1 Scripps Laboratories Company Details
11.9.2 Scripps Laboratories Business Overview
11.9.3 Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Introduction
11.9.4 Scripps Laboratories Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2024)
11.9.5 Scripps Laboratories Recent Developments
11.10 Alphamab Oncology
11.10.1 Alphamab Oncology Company Details
11.10.2 Alphamab Oncology Business Overview
11.10.3 Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Introduction
11.10.4 Alphamab Oncology Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2024)
11.10.5 Alphamab Oncology Recent Developments
11.11 Hunan Jingfeng Pharmaceutical
11.11.1 Hunan Jingfeng Pharmaceutical Company Details
11.11.2 Hunan Jingfeng Pharmaceutical Business Overview
11.11.3 Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Introduction
11.11.4 Hunan Jingfeng Pharmaceutical Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2024)
11.11.5 Hunan Jingfeng Pharmaceutical Recent Developments
11.12 Qilu Pharmaceutical
11.12.1 Qilu Pharmaceutical Company Details
11.12.2 Qilu Pharmaceutical Business Overview
11.12.3 Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Introduction
11.12.4 Qilu Pharmaceutical Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2024)
11.12.5 Qilu Pharmaceutical Recent Developments
11.13 Beijing SL Pharmaceutical
11.13.1 Beijing SL Pharmaceutical Company Details
11.13.2 Beijing SL Pharmaceutical Business Overview
11.13.3 Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Introduction
11.13.4 Beijing SL Pharmaceutical Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2024)
11.13.5 Beijing SL Pharmaceutical Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Recombinant Human Follicle-stimulating Hormone Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2034
Table 2. Key Players of 75IU
Table 3. Key Players of 150IU
Table 4. Key Players of Others
Table 5. Global Recombinant Human Follicle-stimulating Hormone Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2034
Table 6. Global Recombinant Human Follicle-stimulating Hormone Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 7. Global Recombinant Human Follicle-stimulating Hormone Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Recombinant Human Follicle-stimulating Hormone Market Share by Region (2018-2024)
Table 9. Global Recombinant Human Follicle-stimulating Hormone Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 10. Global Recombinant Human Follicle-stimulating Hormone Market Share by Region (2024-2034)
Table 11. Recombinant Human Follicle-stimulating Hormone Market Trends
Table 12. Recombinant Human Follicle-stimulating Hormone Market Drivers
Table 13. Recombinant Human Follicle-stimulating Hormone Market Challenges
Table 14. Recombinant Human Follicle-stimulating Hormone Market Restraints
Table 15. Global Recombinant Human Follicle-stimulating Hormone Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Recombinant Human Follicle-stimulating Hormone Revenue Share by Players (2018-2024)
Table 17. Global Top Recombinant Human Follicle-stimulating Hormone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Follicle-stimulating Hormone as of 2022)
Table 18. Global Recombinant Human Follicle-stimulating Hormone Industry Ranking 2021 VS 2022 VS 2024
Table 19. Global 5 Largest Players Market Share by Recombinant Human Follicle-stimulating Hormone Revenue (CR5 and HHI) & (2018-2024)
Table 20. Global Key Players of Recombinant Human Follicle-stimulating Hormone, Headquarters and Area Served
Table 21. Global Key Players of Recombinant Human Follicle-stimulating Hormone, Product and Application
Table 22. Global Key Players of Recombinant Human Follicle-stimulating Hormone, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Recombinant Human Follicle-stimulating Hormone Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Type (2018-2024)
Table 26. Global Recombinant Human Follicle-stimulating Hormone Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 27. Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Type (2024-2034)
Table 28. Global Recombinant Human Follicle-stimulating Hormone Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Recombinant Human Follicle-stimulating Hormone Revenue Share by Application (2018-2024)
Table 30. Global Recombinant Human Follicle-stimulating Hormone Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 31. Global Recombinant Human Follicle-stimulating Hormone Revenue Share by Application (2024-2034)
Table 32. North America Recombinant Human Follicle-stimulating Hormone Market Size by Type (2018-2024) & (US$ Million)
Table 33. North America Recombinant Human Follicle-stimulating Hormone Market Size by Type (2024-2034) & (US$ Million)
Table 34. North America Recombinant Human Follicle-stimulating Hormone Market Size by Application (2018-2024) & (US$ Million)
Table 35. North America Recombinant Human Follicle-stimulating Hormone Market Size by Application (2024-2034) & (US$ Million)
Table 36. North America Recombinant Human Follicle-stimulating Hormone Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 37. North America Recombinant Human Follicle-stimulating Hormone Market Size by Country (2018-2024) & (US$ Million)
Table 38. North America Recombinant Human Follicle-stimulating Hormone Market Size by Country (2024-2034) & (US$ Million)
Table 39. Europe Recombinant Human Follicle-stimulating Hormone Market Size by Type (2018-2024) & (US$ Million)
Table 40. Europe Recombinant Human Follicle-stimulating Hormone Market Size by Type (2024-2034) & (US$ Million)
Table 41. Europe Recombinant Human Follicle-stimulating Hormone Market Size by Application (2018-2024) & (US$ Million)
Table 42. Europe Recombinant Human Follicle-stimulating Hormone Market Size by Application (2024-2034) & (US$ Million)
Table 43. Europe Recombinant Human Follicle-stimulating Hormone Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 44. Europe Recombinant Human Follicle-stimulating Hormone Market Size by Country (2018-2024) & (US$ Million)
Table 45. Europe Recombinant Human Follicle-stimulating Hormone Market Size by Country (2024-2034) & (US$ Million)
Table 46. China Recombinant Human Follicle-stimulating Hormone Market Size by Type (2018-2024) & (US$ Million)
Table 47. China Recombinant Human Follicle-stimulating Hormone Market Size by Type (2024-2034) & (US$ Million)
Table 48. China Recombinant Human Follicle-stimulating Hormone Market Size by Application (2018-2024) & (US$ Million)
Table 49. China Recombinant Human Follicle-stimulating Hormone Market Size by Application (2024-2034) & (US$ Million)
Table 50. Asia Recombinant Human Follicle-stimulating Hormone Market Size by Type (2018-2024) & (US$ Million)
Table 51. Asia Recombinant Human Follicle-stimulating Hormone Market Size by Type (2024-2034) & (US$ Million)
Table 52. Asia Recombinant Human Follicle-stimulating Hormone Market Size by Application (2018-2024) & (US$ Million)
Table 53. Asia Recombinant Human Follicle-stimulating Hormone Market Size by Application (2024-2034) & (US$ Million)
Table 54. Asia Recombinant Human Follicle-stimulating Hormone Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 55. Asia Recombinant Human Follicle-stimulating Hormone Market Size by Region (2018-2024) & (US$ Million)
Table 56. Asia Recombinant Human Follicle-stimulating Hormone Market Size by Region (2024-2034) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Recombinant Human Follicle-stimulating Hormone Market Size by Type (2018-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Recombinant Human Follicle-stimulating Hormone Market Size by Type (2024-2034) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Recombinant Human Follicle-stimulating Hormone Market Size by Application (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Recombinant Human Follicle-stimulating Hormone Market Size by Application (2024-2034) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Recombinant Human Follicle-stimulating Hormone Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 62. Middle East, Africa, and Latin America Recombinant Human Follicle-stimulating Hormone Market Size by Country (2018-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Recombinant Human Follicle-stimulating Hormone Market Size by Country (2024-2034) & (US$ Million)
Table 64. Merck Company Details
Table 65. Merck Business Overview
Table 66. Merck Recombinant Human Follicle-stimulating Hormone Product
Table 67. Merck Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2024) & (US$ Million)
Table 68. Merck Recent Developments
Table 69. Ferring Company Details
Table 70. Ferring Business Overview
Table 71. Ferring Recombinant Human Follicle-stimulating Hormone Product
Table 72. Ferring Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2024) & (US$ Million)
Table 73. Ferring Recent Developments
Table 74. Livzon Company Details
Table 75. Livzon Business Overview
Table 76. Livzon Recombinant Human Follicle-stimulating Hormone Product
Table 77. Livzon Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2024) & (US$ Million)
Table 78. Livzon Recent Developments
Table 79. Gedeon Richter Company Details
Table 80. Gedeon Richter Business Overview
Table 81. Gedeon Richter Recombinant Human Follicle-stimulating Hormone Product
Table 82. Gedeon Richter Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2024) & (US$ Million)
Table 83. Gedeon Richter Recent Developments
Table 84. GenSci Company Details
Table 85. GenSci Business Overview
Table 86. GenSci Recombinant Human Follicle-stimulating Hormone Product
Table 87. GenSci Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2024) & (US$ Million)
Table 88. GenSci Recent Developments
Table 89. Teva Company Details
Table 90. Teva Business Overview
Table 91. Teva Recombinant Human Follicle-stimulating Hormone Product
Table 92. Teva Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2024) & (US$ Million)
Table 93. Teva Recent Developments
Table 94. ChangChun High & New Technology Company Details
Table 95. ChangChun High & New Technology Business Overview
Table 96. ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Product
Table 97. ChangChun High & New Technology Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2024) & (US$ Million)
Table 98. ChangChun High & New Technology Recent Developments
Table 99. ABL Company Details
Table 100. ABL Business Overview
Table 101. ABL Recombinant Human Follicle-stimulating Hormone Product
Table 102. ABL Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2024) & (US$ Million)
Table 103. ABL Recent Developments
Table 104. Scripps Laboratories Company Details
Table 105. Scripps Laboratories Business Overview
Table 106. Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Product
Table 107. Scripps Laboratories Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2024) & (US$ Million)
Table 108. Scripps Laboratories Recent Developments
Table 109. Alphamab Oncology Company Details
Table 110. Alphamab Oncology Business Overview
Table 111. Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Product
Table 112. Alphamab Oncology Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2024) & (US$ Million)
Table 113. Alphamab Oncology Recent Developments
Table 114. Hunan Jingfeng Pharmaceutical Company Details
Table 115. Hunan Jingfeng Pharmaceutical Business Overview
Table 116. Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product
Table 117. Hunan Jingfeng Pharmaceutical Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2024) & (US$ Million)
Table 118. Hunan Jingfeng Pharmaceutical Recent Developments
Table 119. Qilu Pharmaceutical Company Details
Table 120. Qilu Pharmaceutical Business Overview
Table 121. Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product
Table 122. Qilu Pharmaceutical Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2024) & (US$ Million)
Table 123. Qilu Pharmaceutical Recent Developments
Table 124. Beijing SL Pharmaceutical Company Details
Table 125. Beijing SL Pharmaceutical Business Overview
Table 126. Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product
Table 127. Beijing SL Pharmaceutical Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2024) & (US$ Million)
Table 128. Beijing SL Pharmaceutical Recent Developments
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Recombinant Human Follicle-stimulating Hormone Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 2. Global Recombinant Human Follicle-stimulating Hormone Market Share by Type: 2022 VS 2034
Figure 3. 75IU Features
Figure 4. 150IU Features
Figure 5. Others Features
Figure 6. Global Recombinant Human Follicle-stimulating Hormone Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Recombinant Human Follicle-stimulating Hormone Market Share by Application: 2022 VS 2034
Figure 8. Infertility Treatment Case Studies
Figure 9. Assisted Reproductive Technology Case Studies
Figure 10. Recombinant Human Follicle-stimulating Hormone Report Years Considered
Figure 11. Global Recombinant Human Follicle-stimulating Hormone Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 12. Global Recombinant Human Follicle-stimulating Hormone Market Size, (US$ Million), 2018 VS 2022 VS 2034
Figure 13. Global Recombinant Human Follicle-stimulating Hormone Market Share by Region: 2022 VS 2034
Figure 14. Global Recombinant Human Follicle-stimulating Hormone Market Share by Players in 2022
Figure 15. Global Top Recombinant Human Follicle-stimulating Hormone Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Follicle-stimulating Hormone as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Recombinant Human Follicle-stimulating Hormone Revenue in 2022
Figure 17. North America Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 18. North America Recombinant Human Follicle-stimulating Hormone Market Share by Type (2018-2034)
Figure 19. North America Recombinant Human Follicle-stimulating Hormone Market Share by Application (2018-2034)
Figure 20. North America Recombinant Human Follicle-stimulating Hormone Market Share by Country (2018-2034)
Figure 21. United States Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Canada Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Europe Recombinant Human Follicle-stimulating Hormone Market Size YoY (2018-2034) & (US$ Million)
Figure 24. Europe Recombinant Human Follicle-stimulating Hormone Market Share by Type (2018-2034)
Figure 25. Europe Recombinant Human Follicle-stimulating Hormone Market Share by Application (2018-2034)
Figure 26. Europe Recombinant Human Follicle-stimulating Hormone Market Share by Country (2018-2034)
Figure 27. Germany Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. France Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. U.K. Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Italy Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Russia Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Nordic Countries Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. China Recombinant Human Follicle-stimulating Hormone Market Size YoY (2018-2034) & (US$ Million)
Figure 34. China Recombinant Human Follicle-stimulating Hormone Market Share by Type (2018-2034)
Figure 35. China Recombinant Human Follicle-stimulating Hormone Market Share by Application (2018-2034)
Figure 36. Asia Recombinant Human Follicle-stimulating Hormone Market Size YoY (2018-2034) & (US$ Million)
Figure 37. Asia Recombinant Human Follicle-stimulating Hormone Market Share by Type (2018-2034)
Figure 38. Asia Recombinant Human Follicle-stimulating Hormone Market Share by Application (2018-2034)
Figure 39. Asia Recombinant Human Follicle-stimulating Hormone Market Share by Region (2018-2034)
Figure 40. Japan Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. South Korea Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. China Taiwan Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Southeast Asia Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. India Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Australia Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Recombinant Human Follicle-stimulating Hormone Market Size YoY (2018-2034) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Recombinant Human Follicle-stimulating Hormone Market Share by Type (2018-2034)
Figure 48. Middle East, Africa, and Latin America Recombinant Human Follicle-stimulating Hormone Market Share by Application (2018-2034)
Figure 49. Middle East, Africa, and Latin America Recombinant Human Follicle-stimulating Hormone Market Share by Country (2018-2034)
Figure 50. Brazil Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 51. Mexico Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 52. Turkey Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 53. Saudi Arabia Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 54. Israel Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 55. GCC Countries Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 56. Merck Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2018-2024)
Figure 57. Ferring Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2018-2024)
Figure 58. Livzon Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2018-2024)
Figure 59. Gedeon Richter Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2018-2024)
Figure 60. GenSci Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2018-2024)
Figure 61. Teva Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2018-2024)
Figure 62. ChangChun High & New Technology Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2018-2024)
Figure 63. ABL Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2018-2024)
Figure 64. Scripps Laboratories Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2018-2024)
Figure 65. Alphamab Oncology Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2018-2024)
Figure 66. Hunan Jingfeng Pharmaceutical Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2018-2024)
Figure 67. Qilu Pharmaceutical Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2018-2024)
Figure 68. Beijing SL Pharmaceutical Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2018-2024)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed